Brief: Synact Pharma AB Rights Issue Oversubscribed
14/05/2018 08:04
SynAct Pharma AB SYNACT.TE :
* RIGHTS ISSUE OVERSUBSCRIBED
* GETS PROCEEDS OF ABOUT SEK 22.4 MILLION IN RIGHTS ISSUE
BEFORE
ISSUE COSTS
Source text for Eikon: ID:nWkr2QjMs6
Further company coverage: SYNACT.TE
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026